Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases

Lippert AH. et al, (2024), Immunity

The immunology of multiple sclerosis.

Attfield KE. et al, (2022), Nat Rev Immunol

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis

Kaufmann M. et al, (2021), Med, 2, 296 - 312.e8

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient

Wurm H. et al, (2020), Multiple Sclerosis Journal, 26, 1261 - 1264

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Structural and regulatory diversity shape HLA-C protein expression levels

Kaur G. et al, (2017), Nature Communications, 8

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

Dendrou CA. et al, (2016), Science Translational Medicine, 8

Multiple sclerosis

Rühl G. et al, (2016), Neurology - Neuroimmunology Neuroinflammation, 3, e241 - e241

Class II HLA interactions modulate genetic risk for multiple sclerosis

(2015), Nature Genetics, 47, 1107 - 1113

CD8+MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis

Willing A. et al, (2014), European Journal of Immunology, 44, 3119 - 3128

TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis

Attfield KE. and Fugger L., (2013), The Journal of Immunology, 190, 3015 - 3017

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Gregory AP. et al, (2012), Nature, 488, 508 - 511

Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis

Attfield KE. et al, (2012), Immunological Reviews, 248, 10 - 22

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Vergo S. et al, (2011), Brain, 134, 571 - 584

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Vergo S. et al, (2011), Brain, 134, 571 - 584

The role of antigenic modulation in controlling the efficacy of anti-CD20 monoclonal antibodies

Beers SA. et al, (2008), IMMUNOLOGY, 125, 48 - 49

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation

Beers SA. et al, (2008), Blood, 112, 4170 - 4177

Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells

Taraban VY. et al, (2008), The Journal of Immunology, 180, 4615 - 4620

Include forthcoming?